NHIC is a nationally appointed Programme Office that works with Public Health Institutions across Singapore to identify and commercialise promising clinical innovations. NHIC funds the translation and development of medical innovations from Singapore’s clinical sector, and provides strategic guidance and connection to industry partners, accelerating the pathway to impact in healthcare.
Established since 2014, the office has supported several projects and companies in the development and implementation of innovative medical technologies and services, improving the standard of healthcare in Singapore and beyond. NHIC is a programme of the Consortium for Clinical Research and Innovation, Singapore (CRIS).
For more information, please visit https://www.nhic.sg
NalaGenetics is a biotechnology company that focuses on preventive care. It aims to assist people in achieving better nutrition, finding optimal medications, and detecting critical illnesses early by analyzing their unique DNA. Founded by an international team of scientists from the Genome Institute of Singapore, NalaGenetics’ proprietary, patent-protected technology is trusted by doctors, hospitals, and laboratories in Asia and Europe.
For more information, go to www.nalagenetics.com
Topics of discussion:
- How do public institutions enhance partnerships and collaborations with health tech startups?
- What are the major challenges that health tech startups encounter when it comes to navigating regulations, scaling health tech solutions, and gaining user acceptance and adoption?